Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. [PDF]
, 2015 Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of mass drug administration (MDA) has been adopted by the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Alexander, Neal DE
core +1 more source
A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. [PDF]
, 2013 BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review
Fischer, Peter U +8 more
core +1 more source
Uptake of mass drug administration programme for schistosomiasis control in Koome Islands, Central Uganda. [PDF]
, 2015 INTRODUCTION: Schistosomiasis is one of the neglected tropical diseases targeted for elimination in Uganda through the Mass Drug Administration (MDA) programme.
Nuwaha, Fred +23 more
core +1 more source
Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea. [PDF]
, 2011 BACKGROUND: Acute painful swelling of the extremities and scrotum are debilitating clinical manifestations of Wuchereria bancrofti infection. The ongoing global program to eliminate filariasis using mass drug administration is expected to decrease this ...
Alexander Neal D. E. +43 more
core +1 more source
Antimalarial mass drug administration: ethical considerations [PDF]
International Health, 2016 Falciparum malaria is a major cause of death and illness in tropical countries, particularly in childhood. In endemic countries, a significant proportion of the community is infected with malaria asymptomatically. One promising way to eliminate malaria is to give the entire population malaria treatment. This is called mass drug administration (MDA) and
Cheah, PY, White, NJ
openaire +2 more sources
Will mass drug administration eliminate lymphatic filariasis? Evidence from northern coastal Tanzania [PDF]
, 2012 Copyright @ 2012 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and 85 reproduction in any medium, provided the original author and source
Allen, Tim +3 more
core +1 more source
Stopping azithromycin mass drug administration for trachoma: A systematic review.
PLoS Neglected Tropical Diseases, 2021 The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years.
Hamidah Mahmud +8 more
doaj +1 more source
Lymphatic Filariasis Control in Tanzania: Effect of Six Rounds of Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission. [PDF]
, 2013 Control of lymphatic filariasis (LF) in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. We present findings from a detailed study
Simonsen, Paul E +17 more
core +2 more sources
Ethical considerations in an era of mass drug administration [PDF]
Parasites & Vectors, 2013 In a Plenary debate at the 51st Spring meeting of the British Society of Parasitology, Bristol, UK, April 8-11, 2013, the bioethicist James Wilson used the value of a life in the present and future to question the effectiveness of current health strategies.
Wharam, Barney, Lazarou, Luke
openaire +4 more sources
Parasites & Vectors, 2015 Background With ambitious targets to eliminate lymphatic filariasis over the coming years, there is a need to identify optimal strategies to achieve them in areas with different baseline prevalence and stages of control.
M. A. Irvine +6 more
doaj +1 more source